EDMOND DE ROTHSCHILD HOLDING S.A. - ENLIVEX THERAPEUTICS LTD ownership

ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 24 filers reported holding ENLIVEX THERAPEUTICS LTD in Q4 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ENLIVEX THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$20,540
-39.9%
13,0000.0%0.00%
-100.0%
Q2 2023$34,190
-27.7%
13,0000.0%0.00%0.0%
Q1 2023$47,320
-6.7%
13,0000.0%0.00%0.0%
Q4 2022$50,700
-7.8%
13,0000.0%0.00%0.0%
Q3 2022$55,000
-6.8%
13,0000.0%0.00%0.0%
Q2 2022$59,000
-19.2%
13,0000.0%0.00%
-50.0%
Q1 2022$73,000
-9.9%
13,0000.0%0.00%0.0%
Q4 2021$81,000
-36.7%
13,0000.0%0.00%
-33.3%
Q3 2021$128,000
+10.3%
13,0000.0%0.00%0.0%
Q2 2021$116,000
-19.4%
13,0000.0%0.00%
-25.0%
Q1 2021$144,00013,0000.00%
Other shareholders
ENLIVEX THERAPEUTICS LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Lee Capital Holdings LLC 11,805$46,4820.07%
Susquehanna International Group Ltd. 18,887$72,0730.03%
Compagnie Lombard Odier SCmA 50,000$190,0000.01%
EDMOND DE ROTHSCHILD HOLDING S.A. 13,000$50,7000.00%
OSAIC HOLDINGS, INC. 400$2,0000.00%
BANK OF AMERICA CORP /DE/ 647$2,5470.00%
WELLS FARGO & COMPANY/MN 11,746$46,2500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 13,499$52,6460.00%
GEODE CAPITAL MANAGEMENT, LLC 10,420$400.00%
View complete list of ENLIVEX THERAPEUTICS LTD shareholders